Cargando…
Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury
INTRODUCTION: Acute kidney injury (AKI) can evolve quickly and clinical measures of function often fail to detect AKI at a time when interventions are likely to provide benefit. Identifying early markers of kidney damage has been difficult due to the complex nature of human AKI, in which multiple et...
Ejemplares similares
-
TIMP2•IGFBP7 biomarker panel accurately predicts acute kidney injury in high-risk surgical patients
por: Gunnerson, Kyle J., et al.
Publicado: (2016) -
Identification and validation of biomarkers of persistent acute kidney injury: the RUBY study
por: Hoste, Eric, et al.
Publicado: (2020) -
Use of Cell Cycle Arrest Biomarkers in Conjunction With Classical Markers of Acute Kidney Injury
por: Joannidis, Michael, et al.
Publicado: (2019) -
External validation of urinary C–C motif chemokine ligand 14 (CCL14) for prediction of persistent acute kidney injury
por: Bagshaw, Sean M., et al.
Publicado: (2021) -
Kinetics of Urinary Cell Cycle Arrest Markers for Acute Kidney Injury Following Exposure to Potential Renal Insults
por: Ostermann, Marlies, et al.
Publicado: (2018)